Advanced search
Publication Cover
Journal of Hepatocellular Carcinoma Volume 9, 2022 - Issue
Submit an article Journal homepage
114
Views
2
CrossRef citations to date
0
Altmetric
Original Research

CtBP1 Mediates Hypoxia-Induced Sarcomatoid Transformation in Hepatocellular Carcinoma

Xiaoling Zhang1 Department of Physiology, Faculty of Basic Medical Science, Guilin Medical University, Guilin, People’s Republic of China;2 Key Laboratory of Tumor Immunology and Microenvironmental Regulation of Guangxi, Guilin Medical University, Guilin, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5345-6608
ORCID Icon,
Xiaoyu Wang3 Department of Pathology, the Second Affiliated Hospital of Guilin Medical University, Guilin, People’s Republic of China
,
Liting Jia4 Department of Pathology, Affiliated Hospital of Hebei Engineering University, Handan, People’s Republic of China
,
Yang Yang5 Department of Pathology, General Hospital of Central Theater Command, Wuhan, People’s Republic of China
,
Fan Yang3 Department of Pathology, the Second Affiliated Hospital of Guilin Medical University, Guilin, People’s Republic of China
&
Shengjun Xiao2 Key Laboratory of Tumor Immunology and Microenvironmental Regulation of Guangxi, Guilin Medical University, Guilin, People’s Republic of China;3 Department of Pathology, the Second Affiliated Hospital of Guilin Medical University, Guilin, People’s Republic of China;6 Department of Pathology, Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, the Second Affiliated Hospital of Guilin Medical University, Guilin, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6731-1899
ORCID Icon
Pages 57-67 | Published online: 11 Feb 2022

References

  • Shafizadeh N, Kakar S. Hepatocellular carcinoma: histologic subtypes. Surg Pathol Clin. 2013;6(2):367–384. doi:10.1016/j.path.2013.03.007
  • Liao SH, Su TH, Jeng YM, et al. Clinical manifestations and outcomes of patients with sarcomatoid hepatocellular carcinoma. Hepatology. 2019;69(1):209–221. doi:10.1002/hep.30162
  • Wang JP, Yao ZG, Sun YW, et al. Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma. World J Gastroenterol. 2020;26(29):4327–4342. doi:10.3748/wjg.v26.i29.4327
  • Wu L, Tsilimigras DI, Farooq A, et al. Management and outcomes among patients with sarcomatoid hepatocellular carcinoma: a population-based analysis. Cancer. 2019;125(21):3767–3775. doi:10.1002/cncr.32396
  • Luo C, Xin H, Yin D, et al. Characterization of immune infiltration in sarcomatoid hepatocellular carcinoma. Aging (Albany NY). 2021;13(11):15126–15138. doi:10.18632/aging.203076
  • Malouf GG, Flippot R, Dong Y, et al. Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers. Sci Rep. 2020;10(1):701. doi:10.1038/s41598-020-57534-5
  • Sung CO, Choi H, Lee KW, Kim SH. Sarcomatoid carcinoma represents a complete phenotype with various pathways of epithelial mesenchymal transition. J Clin Pathol. 2013;66(7):601–606. doi:10.1136/jclinpath-2012-201271
  • Conant JL, Peng Z, Evans MF, Naud S, Cooper K. Sarcomatoid renal cell carcinoma is an example of epithelial–mesenchymal transition. J Clin Pathol. 2011;64(12):1088–1092. doi:10.1136/jclinpath-2011-200216
  • Tickoo SK, Alden D, Olgac S, et al. Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma. J Urol. 2007;177(4):1258–1263. doi:10.1016/j.juro.2006.11.100
  • Zhang Q, Wang SY, Nottke AC, Rocheleau JV, Piston DW, Goodman RH. Redox sensor CtBP mediates hypoxia-induced tumor cell migration. Proc Natl Acad Sci U S A. 2006;103(24):9029–9033. doi:10.1073/pnas.0603269103
  • Zhang XL, Huang CX, Zhang J, Inoue A, Zeng SE, Xiao SJ. CtBP1 is involved in epithelial-mesenchymal transition and is a potential therapeutic target for hepatocellular carcinoma. Oncol Rep. 2013;30(2):809–814. doi:10.3892/or.2013.2537
  • Vaupel P, Multhoff G. Fatal alliance of hypoxia-/HIF-1alpha-driven microenvironmental traits promoting cancer progression. Adv Exp Med Biol. 2020;1232:169–176. doi:10.1007/978-3-030-34461-0_21
  • Ku JH, Park YH, Myung JK, Moon KC, Kwak C, Kim HH. Expression of hypoxia inducible factor-1alpha and 2alpha in conventional renal cell carcinoma with or without sarcomatoid differentiation. Urol Oncol. 2011;29(6):731–737. doi:10.1016/j.urolonc.2009.08.007
  • Hsieh MS, Lin MW, Lee YH. Lung adenocarcinoma with sarcomatoid transformation after tyrosine kinase inhibitor treatment and chemotherapy. Lung Cancer. 2019;137:76–84. doi:10.1016/j.lungcan.2019.08.029
  • Li X, Wu D, Liu H, Chen J. Pulmonary sarcomatoid carcinoma: progress, treatment and expectations. Ther Adv Med Oncol. 2020;12:1758835920950207. doi:10.1177/1758835920950207
  • Guo CC, Majewski T, Zhang L, et al. Dysregulation of EMT drives the progression to clinically aggressive sarcomatoid bladder cancer. Cell Rep. 2019;27(6):1781–1793 e4. doi:10.1016/j.celrep.2019.04.048
  • Manzotti G, Torricelli F, Benedetta D, et al. An epithelial-to-mesenchymal transcriptional switch triggers evolution of pulmonary sarcomatoid carcinoma (PSC) and identifies dasatinib as new therapeutic option. Clin Cancer Res. 2019;25(7):2348–2360. doi:10.1158/1078-0432.CCR-18-2364
  • Seol MA, Chu IS, Lee MJ, et al. Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma. BMC Cancer. 2011;11:78. doi:10.1186/1471-2407-11-78
  • Tam SY, Wu VWC, Law HKW. Hypoxia-induced epithelial-mesenchymal transition in cancers: HIF-1alpha and beyond. Front Oncol. 2020;10:486. doi:10.3389/fonc.2020.00486
  • Yamada S, Utsunomiya T, Morine Y, et al. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy. Ann Surg Oncol. 2014;21(Suppl 3):S436–S442. doi:10.1245/s10434-014-3575-z
  • Chen L, Yang Y, Xu L, Liu R, Wang Y. Integrated gene expression profiling and chromatin immunoprecipitation followed by sequencing: analysis of the C-terminal binding protein in breast cancer. J Obstet Gynaecol Res. 2017;43(9):1472–1480. doi:10.1111/jog.13400

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.